The present stock price for EyePoint Pharmaceuticals Inc (EYPT) is $11.51. In the last trading session, the stock made a considerable jump, reaching $68.0 after an opening price of $11.51. The stock briefly fell to $23.0 before ending the session at $11.04.
EyePoint Pharmaceuticals Inc experienced a somewhat steady performance in the stock market. The company’s stock reached a 1-year high of $13.98 on 10/28/24, while the lowest price for the same period was registered at $3.91 on 04/09/25.
52-week price history of EYPT Stock
Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. EyePoint Pharmaceuticals Inc’s current trading price is -17.70% away from its 52-week high, while its distance from the 52-week low is 194.37%. The stock’s price range during the 52-week period has remained between $3.91 and $13.98. In the Healthcare sector, the company’s shares saw a trading volume of around 1.06 million for the day, which was evidently higher than the average daily volume of 0.79 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
EyePoint Pharmaceuticals Inc (EYPT) has experienced a quarterly rise of 85.35% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 793.36M and boasts a workforce of 165 employees.
A Closer Look at Analysts’ Ratings for EyePoint Pharmaceuticals Inc
As of right now, 9 analysts are rating EyePoint Pharmaceuticals Inc as a BUY, 4 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 8.13, with a change in price of +5.60. Similarly, EyePoint Pharmaceuticals Inc recorded 788,158 in trading volume during the last 100 days, posting a change of +94.75%.
Examining EYPT’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for EYPT stands at 0.09. Similarly, the long-term debt-to-equity ratio is also 0.09.
EYPT Stock Stochastic Average
As of today, EyePoint Pharmaceuticals Inc’s raw stochastic average for the last 50 days stands at 95.20%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 99.53%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 89.84% and 87.59%, respectively.
EYPT Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The index has shown a price gain of 45.15% this year. Over the last six months, there has been a weaker performance of 77.90%. The price of EYPT fallen by 10.14% during the last 30 days period. For the last 5-days stocks have improved 4.54%.
